Edition:
United States

Elekta AB (publ) (EKTAb.ST)

EKTAb.ST on Stockholm Stock Exchange

79.55SEK
11:29am EDT
Change (% chg)

-0.35kr (-0.44%)
Prev Close
79.90kr
Open
80.00kr
Day's High
80.15kr
Day's Low
79.15kr
Volume
786,858
Avg. Vol
1,387,707
52-wk High
95.90kr
52-wk Low
70.00kr

Chart for

About

Elekta publ AB is a Sweden-based human care company that develops and sells clinical solutions for the treatment of cancer and brain disorder. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer... (more)

Overall

Beta: 0.92
Market Cap(Mil.): kr29,450.15
Shares Outstanding(Mil.): 368.59
Dividend: 0.50
Yield (%): 1.25

Financials

  Industry Sector
P/E (TTM): -- 164.04 17.08
EPS (TTM): -- -- --
ROI: -- 9.56 11.26
ROE: -- 14.93 15.09

BRIEF-Mclaren Health Care and Elekta mutually terminate long-term agreement

* Mclaren Health Care and Elekta have mutually agreed to terminate their long-term agreement.

Oct 11 2017

BRIEF- IBA and Elekta enter MOU regarding comprehensive partnership

* ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS Source text for Eikon:

Sep 25 2017

BRIEF-Elekta and IBA partner to advance proton therapy treatments

* Eleketa and Ion Beam Applications (IBA) enter an mou regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Sep 25 2017

BRIEF-Elekta and Brainlab collaborate to streamline treatment workflows for stereotactic radiation therapy

* Elekta and Brainlab collaborate to streamline treatment workflows for stereotactic radiation therapy Source text for Eikon: Further company coverage:

Sep 22 2017

UPDATE 1-Elekta repeats margin target as Q1 core profit lags expectations

Aug 23 Radiotherapy gear maker Elekta posted on Wednesday lower quarterly core earnings than expected, but orders matched forecasts and the firm repeated a full-year margin target.

Aug 23 2017

BRIEF-Elekta Q1 core profit lags expectations, orders in line

* Reuters poll average forecasts were for adjusted EBITA of 244 mln SEK, sales 2,148 mln, orders 2,736 mln

Aug 23 2017

BRIEF-C-RAD to supply advanced surface tracking solution to Swedish Cancer Center Nya Karolinska Solna

* C-RAD TO SUPPLY ADVANCED SURFACE TRACKING SOLUTION TO SWEDISH CANCER CENTER NYA KAROLINSKA SOLNA

Aug 03 2017

BRIEF-Isala and Elekta sign 15- year partnership agreement for optimal cancer care

* Co, Isala signed a 15-year partnership agreement to implement latest developments in oncology and radiotherapy at Isala

Jun 27 2017

UPDATE 1-Elekta shares fall after big Q4 earnings miss

June 1 Swedish radiotherapy equipment maker Elekta posted on Thursday a surprise drop in fiscal fourth-quarter core earnings and order intake fell far below forecasts, sending shares sharply lower.

Jun 01 2017

BRIEF-Elekta Q4 core profit, order intake lags expectations

* Says board of directors propose a dividend of sek 1.00 (0.50) per share for fiscal year 2016/17

Jun 01 2017

Earnings vs. Estimates